Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 34 announcements

Share price

₹1,454.90

Market cap

₹17,891 Cr

Revenue (annual)

₹2,552 Cr

Net profit (annual)

₹564.5 Cr

P/E (TTM)

26.7×Sector 43.8×

Promoter holding

74.85%-0.02% QoQ

FII holding

5.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.